Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included but will usually appear in 24 hrs or less.

Rational Source
Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in Mice. ✅ Go to Publication ✅
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: Issue Pages: e1700738
Pub: 2017 Dec 20 Epub: 2017 Dec 20 Authors Li CC , Liu C , Fu M , Hu KQ , Aizawa K , Takahashi S , Hiroyuki S , Cheng J , von Lintig J , Wang XD ,
Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in Mice. ✅ Go to Publication ✅
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: Issue Pages: e1700738
Pub: 2017 Dec 20 Epub: 2017 Dec 20 Authors Li CC , Liu C , Fu M , Hu KQ , Aizawa K , Takahashi S , Hiroyuki S , Cheng J , von Lintig J , Wang XD ,
Effects of Dietary Lycopene on the Growth Performance, Antioxidant Capacity, Meat Quality, Intestine Histomorphology, and Cecal Microbiota in Broiler Chickens. ✅ Go to Publication ✅
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 14 Issue 2 Pages:
Pub: 2024 Jan 8 Epub: 2024 Jan 8 Authors Wu H , Wang S , Xie J , Ji F , Peng W , Qian J , Shen Q , Hou G ,
Effects of Dietary Lycopene on the Growth Performance, Antioxidant Capacity, Meat Quality, Intestine Histomorphology, and Cecal Microbiota in Broiler Chickens. ✅ Go to Publication ✅
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 14 Issue 2 Pages:
Pub: 2024 Jan 8 Epub: 2024 Jan 8 Authors Wu H , Wang S , Xie J , Ji F , Peng W , Qian J , Shen Q , Hou G ,
Effects of Dietary Lycopene on the Growth Performance, Antioxidant Capacity, Meat Quality, Intestine Histomorphology, and Cecal Microbiota in Broiler Chickens. ✅ Go to Publication ✅
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 14 Issue 2 Pages:
Pub: 2024 Jan 8 Epub: 2024 Jan 8 Authors Wu H , Wang S , Xie J , Ji F , Peng W , Qian J , Shen Q , Hou G ,
Effects of Dietary Lycopene on the Growth Performance, Antioxidant Capacity, Meat Quality, Intestine Histomorphology, and Cecal Microbiota in Broiler Chickens. ✅ Go to Publication ✅
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 14 Issue 2 Pages:
Pub: 2024 Jan 8 Epub: 2024 Jan 8 Authors Wu H , Wang S , Xie J , Ji F , Peng W , Qian J , Shen Q , Hou G ,
Amelioration of Atherosclerosis by lycopene is linked to the modulation of gut microbiota dysbiosis and related gut-heart axis activation in high-fat diet-fed ApoE(-/-) mice. ✅ Go to Publication ✅
Nutrition & metabolism (Nutr Metab (Lond) ) Vol: 20 Issue 1 Pages: 53
Pub: 2023 Dec 1 Epub: 2023 Dec 1 Authors Tu T , Liu H , Liu Z , Liang Y , Tan C , Feng D , Zou J ,
Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-?B/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet. ✅ Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 10 Issue Pages: 1120254
Pub: 2023 Epub: 2023 Mar 23 Authors Gao X , Zhao X , Liu M , Zhao H , Sun Y ,
Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-?B/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet. ✅ Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 10 Issue Pages: 1120254
Pub: 2023 Epub: 2023 Mar 23 Authors Gao X , Zhao X , Liu M , Zhao H , Sun Y ,
Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-?B/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet. ✅ Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 10 Issue Pages: 1120254
Pub: 2023 Epub: 2023 Mar 23 Authors Gao X , Zhao X , Liu M , Zhao H , Sun Y ,
Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-?B/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet. ✅ Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 10 Issue Pages: 1120254
Pub: 2023 Epub: 2023 Mar 23 Authors Gao X , Zhao X , Liu M , Zhao H , Sun Y ,
Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-?B/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet. ✅ Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 10 Issue Pages: 1120254
Pub: 2023 Epub: 2023 Mar 23 Authors Gao X , Zhao X , Liu M , Zhao H , Sun Y ,
Assessing the growth of Staphylococcus aureus and Escherichia coli on fruits and vegetables. ✅ Go to Publication ✅
Journal of infection in developing countries (J Infect Dev Ctries ) Vol: 13 Issue 6 Pages: 480-486
Pub: 2019 Jun 30 Epub: 2019 Jun 30 Authors Kothe CI , Pessoa JP , Malheiros PS , Tondo EC ,

BOOM

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)